Group 1: Technological Innovation and Development - The 2025 Zhongguancun Forum highlights China's commitment to innovation-driven development, with R&D expenditure reaching 3.6 trillion yuan in 2024 and an R&D intensity of 2.68% [1] - China has established technology cooperation with over 160 countries and regions, signing 118 intergovernmental agreements, positioning Beijing as a strategic hub for technological innovation [2] - The forum showcased humanoid robots as a key focus, with applications in the automotive sector, emphasizing the importance of reducing data costs for large-scale industrialization [3][4] Group 2: Advancements in Electric Vehicles - The forum announced significant technological achievements, including the "AI + New Materials" initiative, with Xiaomi's automotive project utilizing advanced materials for enhanced vehicle performance [5] - Li Auto introduced its self-developed operating system, Li Xiang Star Ring OS, aimed at reducing BOM costs by billions annually, marking a significant step in automotive intelligence [6] - Beijing's efforts in promoting technology transfer have led to a thriving ecosystem with nearly 30,000 national high-tech enterprises and significant growth in strategic emerging industries like AI and electric vehicles [7] Group 3: Showcase of Smart New Energy Vehicles - The forum featured a dedicated exhibition area for smart connected new energy vehicles, with Xiaomi showcasing its SU7 models and various in-car products [8] - Innovative technologies such as the rubber-wheeled guided transit vehicle were highlighted, demonstrating advancements in public transport automation and energy efficiency [8][9] - The event underscored the automotive sector's role as a representative of new productive forces, showcasing China's rapid development in this field [9]

Core Viewpoint - Beijing Zhongguancun Science and Technology Development (Holding) Co., Ltd. announced that its subsidiary, Beijing Huasu Pharmaceutical Co., Ltd., has been selected in the 10th batch of national drug centralized procurement for its product, Naloxone Hydrochloride Injection, which is expected to positively impact the company's future performance and market presence [1][2]. Group 1: Product Information - Product Name: Naloxone Hydrochloride Injection - Dosage Form: Injection - Specification: 1ml:1mg - Packaging: 10 vials/box - Indications: Used for reversing respiratory depression caused by opioid drugs, treating opioid overdose, and diagnosing acute opioid overdose [1][2]. Group 2: Procurement Details - Selected Price: 0.99 yuan per vial - Supply Provinces: Inner Mongolia, Liaoning, Jilin, Hunan, Qinghai - Backup Supply Provinces: Beijing, Tianjin, Zhejiang, Anhui, Jiangxi - Selected Company: Beijing Huasu Pharmaceutical Co., Ltd. [2]. Group 3: Impact on the Company - The selected product is classified as a Class A product under the national medical insurance scheme, with a procurement period from the selection date until December 31, 2027 - Medical institutions will prioritize the use of selected products, which is expected to enhance the company's sales channels and market share for Naloxone Hydrochloride Injection - The successful implementation of procurement contracts will contribute positively to the company's operational performance and long-term development [2].

新华社石家庄4月2日电 题：特写：当"世界的中关村"遇见"未来之城" 2017年4月1日，新华社受权发布：中共中央、国务院决定设立河北雄安新区。8年来，雄安新区城市发 展日新月异，科技创新活力迸发。以梅卡曼德为代表的高新技术企业纷纷向雄安新区集聚，其中许多企 业选择入驻雄安新区中关村科技园。 这是雄安新区中关村科技园（2025年3月29日摄，无人机照片）。新华社记者 落飞麟 摄 梅卡曼德机器人科技有限公司工作人员（左）讲解该公司智能机器人产品与技术（2024年11月26日 摄）。新华社记者 落飞麟 摄 新华社记者黄昱璋、白林、落飞麟 走进梅卡曼德机器人科技有限公司的展厅，一款智能机械臂令人眼前一亮：通过公司推出的Mech-GPT 多模态大模型，操作员无需掌握专业知识，只需发出语音指令，即可让机械臂完成复杂任务。 作为国家级专精特新"小巨人"企业，梅卡曼德的主打技术是为传统机械臂装上"眼睛"和"大脑"。目前， 梅卡曼德是全球AI+工业机器人领域融资额最高、技术最全面、案例最多、应用领域最广的公司之一， 其产品远销全球50多个国家和地区。 2024年，梅卡曼德将总部从北京迁至雄安新区，期待在这座"未来之城"大展宏 ...

Core Insights - AI for Science is becoming a significant trend in contemporary scientific research, showcasing immense potential in enhancing research efficiency, transforming research paradigms, and accelerating scientific discoveries [1][2]. Group 1: Development and Impact of AI for Science - AI for Science breaks down three boundaries: the boundaries between disciplines, between theory and experimentation, and between industry and academia [1]. - The approach of AI for Science significantly enhances the capacity for scientific discovery and technological output, thereby improving productivity [2]. - The platform model promoted by AI for Science facilitates collaboration across the industry chain, leading to faster conversion of research results into industry applications [2]. Group 2: Tools and Efficiency - The efficiency of research tools has seen remarkable improvement, exemplified by the Science Navigator, an AI-assisted literature retrieval and research tool developed by the Beijing Academy of Science Intelligence [2]. - Traditional literature research methods are time-consuming and labor-intensive, while AI technology combined with vast literature databases allows for rapid retrieval and concise summarization of relevant scientific research [2]. - This efficiency boost not only optimizes research processes but also opens up more possibilities for interdisciplinary research [2][3]. Group 3: Broader Implications - AI for Science is expected to empower various industries, including energy, materials, chemicals, and biomedicine, leading to profound transformations [4]. - The introduction of AI technology in industrial software could result in efficiency improvements by hundreds of times [4]. - This period is viewed as a historic window of opportunity for addressing shortcomings in the research field and achieving significant advancements [4].

3月27日，2025中关村论坛年会（以下简称"论坛年会"）在北京开幕，吸引全球百余个国家和地区的创 新领袖，共同探讨"新质生产力与全球科技合作"。 今年论坛年会的耐心资本服务新质生产力论坛上，君联资本总裁李家庆透露，社保基金中关村自主创新 专项基金已向16个项目决策投资30亿元，其中：超过70%的资金投向北京，近40%投资企业曾获国家科 技进步奖或承担重大科技攻关项目，"专精特新"企业占比近70%，"小巨人"企业占比约45%。 去年以来，耐心资本在不同场合被多次提及。"耐心资本作为科技、产业、金融三角循环的传动轴，已 成为培育新质生产力的核心动能，'范式变化'正在深刻地影响着中国股权投资市场。"李家庆认为，耐 心资本正逐步深化，成为推动科技创新的关键力量。"在新发展格局下，我们看到股权投资机构迎来了 新的机遇和使命。" 本次论坛年会期间，李家庆接受21世纪经济报道记者采访，介绍了社保基金中关村自主创新专项基金的 情况，以及团队对"耐心资本北京模式"的探索和实践。在他看来，"耐心资本北京模式"不仅是通过制度 创新释放经济创新动能的战略实践，还在于构建起"有效市场+有为政府+市场化专业机构+北京优势"协 同发力的 ...

Core Points - The 2025 Zhongguancun Forum was held from March 27 to 31 in Beijing, focusing on innovation and collaboration in technology [1] - Shanxi Province actively participated as an innovation cooperation partner, showcasing its achievements in transforming traditional industries and developing emerging sectors [2][5] - The forum included various activities such as the "Shanxi Industrial Digital Innovation Development Conference" and discussions on artificial intelligence and quantum technology [2][4] Group 1 - The forum aimed to enhance Shanxi's global influence and attract high-quality scientific and technological resources [2][5] - Key experts, including members from the Chinese Academy of Engineering, shared insights on advanced topics, contributing to the dialogue on digital industry development in Shanxi [2][5] - The collaboration between Shanxi and Zhongguancun Development Group focuses on building an innovative service system that integrates industry, academia, and finance [3] Group 2 - The forum received positive feedback for Shanxi's transformation practices and openness, creating favorable conditions for attracting high-end resources [5] - The event featured a variety of formats, including promotional videos, expert reports, and high-quality roundtable discussions, showcasing Shanxi's new achievements in transformation [5] - The forum's theme, "New Quality Productivity and International Scientific Cooperation," included multiple sessions and activities aimed at fostering ongoing collaboration [6]

关于盐酸纳洛酮注射液中选第十批全国药品集中采购的公告 共 2 页 证券代码：000931 证券简称：中关村 公告编号：2025-036 北京中关村科技发展（控股）股份有限公司 关于盐酸纳洛酮注射液中选第十批全国药品集中采购的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属公司北 京华素制药股份有限公司（以下简称：北京华素）参与了第十批国家组织药品集 中采购工作，根据国家组织药品联合采购办公室于近日发布的《关于公布全国药 品集中采购（GY-YD2024-2）中选结果的通知》显示，北京华素生产的盐酸纳洛 酮注射液中选本次集中采购，现将相关情况公告如下： 药品名称：盐酸纳洛酮注射液 剂型：注射剂 规格：1ml：1mg 包装规格：10 支/盒 适应症：本品为阿片类受体拮抗药。1、用于阿片类药物复合麻醉药术后， 拮抗该类药物所致的呼吸抑制，促使病人苏醒。2、用于阿片类药物过量，完全 或部分逆转阿片类药物引起的呼吸抑制。3、解救急性乙醇中毒。4、用于急性阿 片类药物过量的诊断。 中选价格：0.99 元/支 ...

海洋覆盖了全球70％以上的面积，但目前只有5％的区域被人类探明。海洋科学日益成为推动全球可持续发展的重要引擎，如何更好地探索海洋、保护 海洋、利用海洋，成为科学家必须面对的重要课题。 日前，在2025中关村论坛年会海洋科学与发展平行论坛上，围绕"推动海洋科学发展、共促国际合作交流"主题，中外科学家聚焦深海生态、碳汇机制、 地质演化与国际合作等前沿议题，分享最新研究成果与合作实践，呼吁深化拓展国际科技合作，共同促进海洋可持续发展。 我国海洋科学研究取得重大成果 "目前海洋只有5％的区域被人类探明。"科学技术部党组成员、秘书长潘晓东致辞时说，"近年来，我国加强海洋基础研究和海洋科学装备研发，取得了 一批具有国际影响力的重大成果。我国研制成功'奋斗者'号全海深载人深潜器、'海斗一号'无人潜水器，'雪龙2'号极地科考船、'梦想'号大洋钻探船等，极 大提升了中国深远海科学研究和探测能力，拓展了海洋科学研究的新领域。" 不仅如此，我国通过实施海洋负排放国际大科学计划，成功发起或牵头实施数字化深海典型生境、全球深渊深潜探索等大科学计划，推动新一轮国际大 洋钻探计划，一大批中国学者逐步走上国际舞台。 潘晓东表示，下一步，要强 ...

Group 1 - The 2025 Zhongguancun Forum highlighted the importance of standardization in enhancing new productivity through the release of two innovative standardization achievements [1][2] - The State Administration for Market Regulation announced the availability of over 30,000 national standards for free download, addressing the urgent need for access to standards [1][2] - Beijing's market regulatory authority emphasized its role in leading high-quality industrial development through standardization, with a focus on key industries such as quantum information and aerospace [2][3] Group 2 - The forum established a regular communication mechanism between 185 key enterprises and 45 national standard committees, resulting in the identification of 25 key standard needs in priority industries [3] - The forum featured international speakers discussing the role of international standards in promoting the collaborative development of emerging technologies [3][4] - A collaborative framework agreement was signed between the National Information Technology Standardization Technical Committee and several enterprises, including Xiaomi, to advance standardization efforts in artificial intelligence [3][4]

Group 1 - The application of artificial intelligence (AI) technology across the entire energy production, consumption, and management chain is expected to significantly enhance energy efficiency and accelerate the transition of traditional high-carbon industries, including the chemical industry, towards green and low-carbon practices [1] - The integration of AI with various fields in the energy sector is seen as a crucial support for promoting green and low-carbon transformation, particularly in areas such as new energy consumption and smart energy use [1] - The Chinese Academy of Sciences plans to deepen collaboration with various sectors to foster innovation through interdisciplinary and cross-field integration, aiming to leverage AI for low-carbon energy development [1] Group 2 - Huawei is advancing the digitalization of energy by merging digital technologies with power electronics to facilitate the low-carbon transition in the industry, exemplified by their smart chemical park solutions implemented in various chemical enterprises [2] - The company has developed intelligent solutions based on AI and ICT technologies for equipment inspection, safety operations, and process optimization, which aim to reduce costs and enhance safety in chemical operations [2] - Huawei intends to continue innovating in areas such as new materials and catalyst development through AI technology, further accelerating the incubation of smart chemical models [2] Group 3 - The traditional development of new chemical technologies typically requires a lengthy process involving multiple stages, often taking over 10 years to establish demonstration plants, highlighting the need for a breakthrough in research paradigms [3] - A team led by an academician from the Chinese Academy of Engineering proposed a dual-driven approach using data and scientific theory to develop a chemical model that addresses the challenges of scaling up from laboratory to factory [3] - The intelligent chemical model 2.0 has established four key platforms for catalytic reactions, process development, pilot scale-up, and factory optimization, providing a new methodology for chemical technology development [3]